Skip to main content

Roche says UK faces losing lead in medical research after Brexit – SWI swissinfo.ch

By July 25, 2016News
roche-logo

roche-logo

Roche, the Swiss pharmaceutical company, has warned that the UK risks losing its lead in medical research after leaving the European Union.  The Swiss group called for Britain to move quickly to replace European regulations with rules that give patients access to innovative treatments or else risk delays in developing crucial medicines. 

{iframe}http://www.swissinfo.ch/eng/pharma_roche-says-uk-faces-losing-lead-in-medical-research-after-brexit/42316186{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.